Related Experiment Videos

Proton spectroscopy in medication-free pediatric attention-deficit/hyperactivity disorder

Frank P MacMaster1, Normand Carrey, Sandra Sparkes

  • 1Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.

Biological Psychiatry
|January 28, 2003
PubMed

Insights

Children with attention-deficit/hyperactivity disorder (ADHD) show elevated frontal-striatal glutamate/glutamine/gamma-aminobutyric acid (Glx) levels. This finding suggests altered glutamatergic neurotransmission in ADHD neuropathology.

Area of Science:

  • Neuroscience
  • Neuroimaging
  • Pediatric Psychiatry

Background:

  • Frontal-striatal pathway dysfunction is linked to attention-deficit/hyperactivity disorder (ADHD) neuropathology.
  • Proton magnetic resonance spectroscopy (1H-MRS) is a valuable tool for investigating brain metabolite levels.

Purpose of the Study:

  • To investigate metabolite levels in the prefrontal cortex of children with ADHD using 1H-MRS.
  • To compare metabolite concentrations between children with ADHD and healthy controls.

Main Methods:

  • Examined nine age- and gender-matched case-control pairs (ages 7-16).
  • Acquired long-echo 1H-MRS scans from the right prefrontal cortex and left striatum.
  • Quantified N-acetyl-aspartate (NAA), glutamate/glutamine/gamma-aminobutyric acid (Glx), creatine/phosphocreatine (Cr), and choline compounds (Cho).

Main Results:

  • Elevated frontal-striatal glutamatergic (Glx) resonances observed in children with ADHD compared to controls.
  • No significant differences in NAA, Cho, or Cr metabolite ratios between groups.

Conclusions:

  • Frontal-striatal Glx resonances may be increased in children with ADHD.
  • Suggests potential alterations in glutamatergic neurotransmission in pediatric ADHD.
Abstract

Related Concept Videos